In addition, the activation of ERK1/2 is required for T4-induced PD-L1 expression [12], and the activation of the PI3K/AKT pathway regulates the expression of PD-L1 in triple-negative breast cancer cells [21]. The gene discussed is CD274; the disease is triple-negative breast carcinoma.